Related Experiment Videos

Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM)

Insights

Liver-kidney microsomal antibodies (LKM) in chronic active hepatitis target liver cell surface antigens. Absorption experiments confirm LKM antibodies react with determinants on both endoplasmic reticulum and plasma membranes.

Area of Science:

  • Immunology
  • Hepatology
  • Autoimmunity

Background:

  • Chronic active hepatitis is an autoimmune liver disease.
  • Liver-kidney microsomal antibodies (LKM) are serological markers associated with certain forms of chronic liver disease.
  • The precise antigenic targets of LKM antibodies have been a subject of investigation.

Purpose of the Study:

  • To investigate the hypothesis that LKM antibodies target antigens shared between hepatocellular endoplasmic reticulum and plasma membranes.
  • To determine if LKM antibodies are directed against cell surface antigens of hepatocytes.

Main Methods:

  • Absorption experiments were conducted using viable isolated hepatocytes and liver microsomes as antigens.
  • Sera from patients positive for LKM antibodies were used in these experiments.

Main Results:

  • Results supported the hypothesis that LKM antibodies recognize antigens present on both hepatocellular endoplasmic reticulum and hepatocyte plasma membranes.
  • LKM antibodies demonstrated restricted organ specificity, reacting with determinants on the liver cell surface.

Conclusions:

  • LKM antibodies are directed against antigenic determinants expressed on the surface of liver cells.
  • This finding contributes to understanding the immunopathology of autoimmune liver diseases characterized by LKM antibodies.

Related Concept Videos